{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:42:38Z","timestamp":1776732158570,"version":"3.51.2"},"reference-count":38,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.3892\/ijo.2013.1905","type":"journal-article","created":{"date-parts":[[2013,4,16]],"date-time":"2013-04-16T07:00:46Z","timestamp":1366095646000},"page":"2001-2008","source":"Crossref","is-referenced-by-count":9,"title":["A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie\u2019s plaques"],"prefix":"10.3892","volume":"42","author":[{"given":"KYUNG HEE","family":"JUNG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YE-LIM","family":"RYU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HEE-SEUNG","family":"LEE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HYUNSEUNG","family":"LEE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MI KWON","family":"SON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HONG HUA","family":"YAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SANG-WON","family":"HONG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JI-KAN","family":"RYU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SUNGWOO","family":"HONG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUN-KYU","family":"SUH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SOON-SUN","family":"HONG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2013,4,16]]},"reference":[{"key":"key20180107181325_b1-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1464-4096.2001.02436.x","article-title":"The prevalence of Peyronie\u2019s disease: results of a large survey","volume":"88","author":"Schwarzer","year":"2001","journal-title":"BJU Int"},{"key":"key20180107181325_b2-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/j.1743-6109.2010.01850.x","article-title":"The management of Peyronie\u2019s disease: evidence-based 2010 guidelines","volume":"7","author":"Ralph","year":"2010","journal-title":"J Sex Med"},{"key":"key20180107181325_b3-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1097\/01.ju.0000127744.18878.f1","article-title":"Subjective and objective analysis of the prevalence of Peyronie\u2019s disease in a population of men presenting for prostate cancer screening","volume":"171","author":"Mulhall","year":"2004","journal-title":"J Urol"},{"key":"key20180107181325_b4-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ucl.2005.08.007","article-title":"Physiology of penile erection and pathophysiology of erectile dysfunction","volume":"32","author":"Dean","year":"2005","journal-title":"Urol Clin North Am"},{"key":"key20180107181325_b5-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ncpuro0201","article-title":"Mechanisms of disease: new insights into the cellular and molecular pathology of Peyronie\u2019s disease","volume":"2","author":"Gonzalez-Cadavid","year":"2005","journal-title":"Nat Clin Pract Urol"},{"key":"key20180107181325_b6-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.eururo.2006.05.002","article-title":"Alterations in the transforming growth factor (TGF)-beta pathway as a potential factor in the pathogenesis of Peyronie\u2019s disease","volume":"51","author":"Haag","year":"2007","journal-title":"Eur Urol"},{"key":"key20180107181325_b7-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1743-6109.2007.00470.x","article-title":"Is there a role for proteomics in Peyronie\u2019s disease?","volume":"4","author":"Domes","year":"2007","journal-title":"J Sex Med"},{"key":"key20180107181325_b8-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0022-5347(01)68236-3","article-title":"An animal model of Peyronie\u2019s-like condition associated with an increase of transforming growth factor beta mRNA and protein expression","volume":"158","author":"El-Sakka","year":"1997","journal-title":"J Urol"},{"key":"key20180107181325_b9-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1042\/BJ20081610","article-title":"The TGF-beta, PI3K\/Akt and PTEN pathways: established and proposed biochemical integration in prostate cancer","volume":"417","author":"Assinder","year":"2009","journal-title":"Biochem J"},{"key":"key20180107181325_b10-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ejca.2004.12.027","article-title":"Functions and regulation of transforming growth factor-beta (TGF-beta) in the prostate","volume":"41","author":"Danielpour","year":"2005","journal-title":"Eur J Cancer"},{"key":"key20180107181325_b11-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","article-title":"The phosphoinositide 3-kinase pathway","volume":"296","author":"Cantley","year":"2002","journal-title":"Science"},{"key":"key20180107181325_b12-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1038\/onc.2008.247","article-title":"The PTEN-PI3K pathway: of feedbacks and cross-talks","volume":"27","author":"Carracedo","year":"2008","journal-title":"Oncogene"},{"key":"key20180107181325_b13-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/gut.2006.103200","article-title":"Expression and functional pharmacology of the bradykinin B1 receptor in the normal and inflamed human gallbladder","volume":"57","author":"Andre","year":"2008","journal-title":"Gut"},{"key":"key20180107181325_b14-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1074\/jbc.M212927200","article-title":"The role of focal adhesion kinase-phosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression","volume":"278","author":"Reif","year":"2003","journal-title":"J Biol Chem"},{"key":"key20180107181325_b15-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0168-8278(00)80067-7","article-title":"Phosphatidylinositol-3 kinase and extracellular signal-regulated kinase mediate the chemotactic and mitogenic effects of insulin-like growth factor-I in human hepatic stellate cells","volume":"32","author":"Gentilini","year":"2000","journal-title":"J Hepatol"},{"key":"key20180107181325_b16-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1128\/MCB.17.3.1595","article-title":"Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt","volume":"17","author":"Kulik","year":"1997","journal-title":"Mol Cell Biol"},{"key":"key20180107181325_b17-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1128\/MCB.21.3.893-901.2001","article-title":"Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1","volume":"21","author":"Kim","year":"2001","journal-title":"Mol Cell Biol"},{"issue":"Pt 1","key":"key20180107181325_b18-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3350001","article-title":"Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation","volume":"335","author":"Coffer","year":"1998","journal-title":"Biochem J"},{"key":"key20180107181325_b19-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.canlet.2012.08.020","article-title":"HS-173, a novel phosphatidylinositol 3-kinase (PI3K) inhibitor, has anti-tumor activity through promoting apoptosis and inhibiting angiogenesis","volume":"328","author":"Lee","year":"2013","journal-title":"Cancer Lett"},{"key":"key20180107181325_b20-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1016\/j.bmcl.2010.10.108","article-title":"Discovery of new azaindole-based PI3Kalpha inhibitors: apoptotic and antiangiogenic effect on cancer cells","volume":"20","author":"Hong","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"key20180107181325_b21-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1111\/j.1743-6109.2010.01753.x","article-title":"Transforming growth factor (TGF)-beta type I receptor kinase (ALK5) inhibitor alleviates profibrotic TGF-beta1 responses in fibroblasts derived from Peyronie\u2019s plaque","volume":"7","author":"Piao","year":"2010","journal-title":"J Sex Med"},{"key":"key20180107181325_b22-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1743-6109.2007.00537.x","article-title":"A survey of primary-care physicians and urologists regarding Peyronie\u2019s disease","volume":"4","author":"LaRochelle","year":"2007","journal-title":"J Sex Med"},{"key":"key20180107181325_b23-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000096927","article-title":"Peyronie\u2019s disease: lights and shadows","volume":"78","author":"Sasso","year":"2007","journal-title":"Urol Int"},{"key":"key20180107181325_b24-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11934-008-0072-6","article-title":"Peyronie\u2019s disease: past, present, future?","volume":"9","author":"Shindel","year":"2008","journal-title":"Curr Urol Rep"},{"key":"key20180107181325_b25-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.eururo.2006.02.059","article-title":"A critical analysis of nonsurgical treatment of Peyronie\u2019s disease","volume":"49","author":"Hauck","year":"2006","journal-title":"Eur Urol"},{"key":"key20180107181325_b26-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1002\/hep.23186","article-title":"Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis","volume":"50","author":"Son","year":"2009","journal-title":"Hepatology"},{"key":"key20180107181325_b27-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"e24663","DOI":"10.1371\/journal.pone.0024663","article-title":"Inhibition of PI3K prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts: the role of class I P110 isoforms","volume":"6","author":"Conte","year":"2011","journal-title":"PLoS One"},{"key":"key20180107181325_b28-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1517\/14728222.2011.577419","article-title":"Peyronie\u2019s disease: perspectives on therapeutic targets","volume":"15","author":"Abdel-Hamid","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"key20180107181325_b29-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2119\/molmed.2012.00010","article-title":"MGMT inhibition restores ERalpha functional sensitivity to antiestrogen therapy","volume":"18","author":"Bobustuc","year":"2012","journal-title":"Mol Med"},{"issue":"Suppl 3","key":"key20180107181325_b30-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1038\/sj.ijir.3900558","article-title":"Inhibition of Peyronie\u2019s plaque fibroblast proliferation by biologic agents","volume":"12","author":"Anderson","year":"2000","journal-title":"Int J Impot Res"},{"key":"key20180107181325_b31-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/sj.ijir.3901170","article-title":"Chromosomal instability is demonstrated by fibroblasts derived from the tunica of men with Peyronie\u2019s disease","volume":"16","author":"Mulhall","year":"2004","journal-title":"Int J Impot Res"},{"key":"key20180107181325_b32-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol Pathol"},{"key":"key20180107181325_b33-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/archfaci.3.2.111","article-title":"Effect of tamoxifen on transforming growth factor beta1 production by keloid and fetal fibroblasts","volume":"3","author":"Mikulec","year":"2001","journal-title":"Arch Facial Plast Surg"},{"key":"key20180107181325_b34-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"e35926","DOI":"10.1371\/journal.pone.0035926","article-title":"Lipopolysaccharide induces lung fibroblast proliferation through Toll-like receptor 4 signaling and the phosphoinositide3-kinase-Akt pathway","volume":"7","author":"He","year":"2012","journal-title":"PLoS One"},{"key":"key20180107181325_b35-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cyto.2011.03.024","article-title":"Induction of cardiac fibroblast lysyl oxidase by TGF-beta1 requires PI3K\/Akt, Smad3, and MAPK signaling","volume":"55","author":"Voloshenyuk","year":"2011","journal-title":"Cytokine"},{"key":"key20180107181325_b36-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.2353\/ajpath.2010.091117","article-title":"Pathologic caveolin-1 regulation of PTEN in idiopathic pulmonary fibrosis","volume":"176","author":"Xia","year":"2010","journal-title":"Am J Pathol"},{"key":"key20180107181325_b37-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0016-5085(97)70144-6","article-title":"Phosphatidylinositol 3-kinase is required for platelet-derived growth factor\u2019s actions on hepatic stellate cells","volume":"112","author":"Marra","year":"1997","journal-title":"Gastroenterology"},{"key":"key20180107181325_b38-ijo-42-06-2001","doi-asserted-by":"crossref","first-page":"11381","DOI":"10.1073\/pnas.0906461107","article-title":"Activity of any class IA PI3K isoform can sustain cell proliferation and survival","volume":"107","author":"Foukas","year":"2010","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2013.1905\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T13:16:01Z","timestamp":1515330961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2013.1905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,16]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,4,16]]},"published-print":{"date-parts":[[2013,6]]}},"alternative-id":["10.3892\/ijo.2013.1905"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2013.1905","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,16]]}}}